Pharmacy Times » Biosimilars
298 FOLLOWERS
Biosimilars Resource Center is a comprehensive resource for clinical news and expert insights on issues related to biosimilar drugs, a biological product that is highly similar to a reference biologic for which there are no clinically meaningful differences in terms of safety, purity, and efficacy. Pharmacy Times is the leading media resource for pharmacists and the pharmacy industry,..
Pharmacy Times » Biosimilars
13h ago
A new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months ..read more
Pharmacy Times » Biosimilars
13h ago
The new administration method, which is co-formulated with rHuPH20, is usable in previous approved nivolumab indications for solid tumors in adult patients ..read more
CDC Report Finds US Residents in Rural Areas Face Higher Percentages of Preventable Premature Deaths
Pharmacy Times » Biosimilars
16h ago
The authors emphasize that additional research addressing disparities and including race, age, and ethnicity should be conducted ..read more
Pharmacy Times » Biosimilars
16h ago
Pharmacists play a multifaceted role beyond dispensing medications, serving as educators, counselors, advocates, and pillars of emotional support for individuals and couples confronting infertility ..read more
Pharmacy Times » Biosimilars
16h ago
In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act ..read more
Pharmacy Times » Biosimilars
16h ago
Merck presented results from the STRIDE-10 phase 3 trial at the 34th European Society of Clinical Microbiology and Infectious Diseases in Barcelona, Spain ..read more
Pharmacy Times » Biosimilars
18h ago
Pharmacists can get involved by counseling patients on when to halt use of supplements, as well as proper use and selection of products ..read more
Pharmacy Times » Biosimilars
3d ago
Compared with women who aren’t experiencing menopausal symptoms, women in the perimenopause stage were approximately 40% more likely to experience depressive symptoms ..read more
Pharmacy Times » Biosimilars
3d ago
Additionally, undocumented Latinx patients were also more likely to have at least 1 prior COVID-19 infection ..read more
Pharmacy Times » Biosimilars
4d ago
Despite the increased survival rates in all 4 evaluated racial groups, both adult and pediatric non-Hispanic African American patients continued to have worse outcomes ..read more